Skip to main content
Log in

Treatment principles of ovarian teratoma with anti-N-methyl-d-aspartate receptor encephalitis

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a recently discovered paraneoplastic limbic encephalitis. Ovarian teratoma is the only tumor clearly related to anti-NMDAR encephalitis occurrence. This study aimed to assess ovarian teratoma for neurological and mental symptoms highly related with anti-NMDAR encephalitis, treatment principles, and prognosis.

Methods

Between June 2011 and October 2014, in Peking Union Medical College Hospital, ten patients with ovarian teratoma associated with anti-NMDAR encephalitis were enrolled. All patients underwent laparoscopic oophorocystectomy followed by immunotherapy.

Results

In nine patients, mental and neurological symptoms were significantly relieved 13.7 ± 5.5 days after surgery; however, symptoms persisted in one patient, who was still hospitalized when writing this paper. During the postoperative follow-up period, seven patients showed no mental symptoms or tumor recurrence; one subject had symptom recurrence 28 days after surgery, while another patient showed suspected tumor recurrence 273 days after operation.

Conclusions

Ovarian teratoma associated with anti-NMDAR encephalitis is usually associated with neurological and mental symptoms at onset. Its manifestations are complex, and nursing care is difficult. Laparoscopic oophorocystectomy followed by immunotherapy led to symptom resolution in most patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tunkel AR, Glaser CA, Bloch KC et al (2008) The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 47(3):303–327. doi:10.1086/589747

    Article  CAS  PubMed  Google Scholar 

  2. Vincent A, Bien CG, Irani SR, Waters P (2011) Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 10(8):759–772. doi:10.1016/S1474-4422(11)70096-5

    Article  CAS  PubMed  Google Scholar 

  3. Kruse JL, Jeffrey JK, Davis MC, Dearlove J, IsHak WW, Brooks JO 3rd (2014) Anti-N-methyl-d-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management. Ann Clin Psychiatry 26(2):111–119

    PubMed  Google Scholar 

  4. Dalmau J, Tuzun E, Wu HY et al (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61(1):25–36. doi:10.1002/ana.21050

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Xu CL, Zhao WQ, Li JM, Wang JW, Wang SW, Wang DX, Liu MY, Qiao SS (2010) One case of anti-NMDAR encephalitis. Chin J Neurol 43(11):781–783

    Google Scholar 

  6. Chapman MR, Vause HE (2011) Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry 168(3):245–251. doi:10.1176/appi.ajp.2010.10020181

    Article  PubMed  Google Scholar 

  7. Schwartz SA (1990) Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders. J Clin Immunol 10(2):81–89

    Article  CAS  PubMed  Google Scholar 

  8. Sathasivam S (2008) Steroids and immunosuppressant drugs in myasthenia gravis. Nat Clin Pract Neurol 4(6):317–327. doi:10.1038/ncpneuro0810

    Article  CAS  PubMed  Google Scholar 

  9. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10(1):63–74. doi:10.1016/S1474-4422(10)70253-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Pelander T, Leino-Kilpi H (2010) Children’s best and worst experiences during hospitalisation. Scand J Caring Sci 24(4):726–733. doi:10.1111/j.1471-6712.2010.00770.x

    Article  PubMed  Google Scholar 

  11. Titulaer MJ, Soffietti R, Dalmau J et al (2011) Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 18(1):19–e13. doi:10.1111/j.1468-1331.2010.03220.x

  12. Graus F, Saiz A (2008) Limbic encephalitis: an expanding concept. Neurology 70(7):500–501. doi:10.1212/01.wnl.0000299189.43164.96

    Article  PubMed  Google Scholar 

  13. Chan LW, Nilsson C, Schepel J, Lynch C (2015) A rare case of anti-N-methyl-d-aspartate receptor encephalitis during pregnancy. N Z Med J 128(1411):89–91

    PubMed  Google Scholar 

  14. Acien P, Acien M, Ruiz-Macia E, Martin-Estefania C (2014) Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases. Orphanet J Rare Dis 9:157. doi:10.1186/s13023-014-0157-x

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zandi MS, Paterson RW, Ellul MA et al (2015) Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes. J Neurol Neurosurg Psychiatry 86(7):708–713. doi:10.1136/jnnp-2014-308736

    Article  PubMed  Google Scholar 

  16. Cleverly K, Gambadauro P, Navaratnarajah R (2014) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis: have you checked the ovaries? Acta Obstet Gynecol Scand 93(7):712–715. doi:10.1111/aogs.12386

    Article  PubMed  Google Scholar 

  17. Tachibana N, Ikeda S (2012) Localization of NMDAR-related epitopes in ovarian teratoma: comparison between patients and controls. Rinsho Shinkeigaku 52(11):982–984

    Article  PubMed  Google Scholar 

  18. Hoftberger R, van Sonderen A, Leypoldt F et al (2015) Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 84(24):2403–2412. doi:10.1212/WNL.0000000000001682

    Article  PubMed  PubMed Central  Google Scholar 

  19. Day GS, Laiq S, Tang-Wai DF, Munoz DG (2014) Abnormal neurons in teratomas in NMDAR encephalitis. JAMA Neurol 71(6):717–724. doi:10.1001/jamaneurol.2014.488

    Article  PubMed  Google Scholar 

  20. Cozzolino M, Bianchi C, Mariani G, Marchi L, Fambrini M, Mecacci F (2015) Therapy and differential diagnosis of posterior reversible encephalopathy syndrome (PRES) during pregnancy and postpartum. Arch Gynecol Obstet 292(6):1217–1223. doi:10.1007/s00404-015-3800-4

    Article  PubMed  Google Scholar 

  21. Florance NR, Davis RL, Lam C et al (2009) Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66(1):11–18. doi:10.1002/ana.21756

    Article  PubMed  PubMed Central  Google Scholar 

  22. Irani SR, Vincent A (2011) NMDA receptor antibody encephalitis. Curr Neurol Neurosci Rep 11(3):298–304. doi:10.1007/s11910-011-0186-y

    Article  CAS  PubMed  Google Scholar 

  23. Varvat J, Lafond P, Page Y, Coudrot M, Reynaud-Salard M, Tardy B (2010) Acute psychiatric syndrome leading young patients to ICU: consider anti-NMDA-receptor antibodies. Anaesth Intensive Care 38(4):748–750

    CAS  PubMed  Google Scholar 

  24. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098. doi:10.1016/S1474-4422(08)70224-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12(2):157–165. doi:10.1016/S1474-4422(12)70310-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhiyuan Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Source of funding

None.

Ethical standards

This study was approved by the Ethics Committee of Peking Union Medical College Hospital and performed in accordance with the 1964 Declaration of Helsinki and later amendments. Informed surgical consent was obtained from all subjects prior to surgery.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bai, Y., Guan, Q., Jiang, J. et al. Treatment principles of ovarian teratoma with anti-N-methyl-d-aspartate receptor encephalitis. Arch Gynecol Obstet 294, 623–629 (2016). https://doi.org/10.1007/s00404-016-4050-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-016-4050-9

Keywords

Navigation